Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens
Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens have?
Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens has 120 citations in the OpenAlex counts ScholarIQ stores.
When was Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens published?
Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens has 2021 year in the ScholarIQ index.
What is the open-access status of Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens?
Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens has gold oa status in the ScholarIQ index.
What is the DOI of Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens?
The DOI for Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens is on the source record.
What is the PMID of Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens?
The PMID for Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens is on the source record.
What is the OpenAlex record for Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens?
The OpenAlex for Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens is on the source record.